Watchlist Price Alert

Edwards Lifesciences Corp... (EW)

NYSE: EW · Real-Time Price · USD

73.86

-0.96 (-1.28%)

At close: Jun 17, 2025, 10:50 AM

Edwards Lifesciences Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Cash & Equivalents	3.05B	1.14B	769M	862.8M	1.18B	1.18B	714.1M	818.3M	930.1M
Short-Term Investments	930.7M	500.5M	446.3M	604M	219.4M	337.8M	242.4M	519.2M	341M
Long-Term Investments	307.9M	583.9M	1.24B	1.83B	801.6M	585.5M	506.3M	567M	532.1M
Other Long-Term Assets	732.4M	463.7M	299.1M	110.8M	119.6M	101.8M	33.6M	108.9M	123.2M
Receivables	727.4M	828.1M	699.1M	664.9M	602.8M	599.1M	537.3M	479.3M	414.6M
Inventory	1.09B	1.17B	875.5M	726.7M	802.3M	640.9M	607M	554.9M	396.6M
Other Current Assets	374.4M	239.3M	195.9M	237.1M	208.2M	168M	131.8M	116.9M	111.8M
Total Current Assets	6.29B	4.04B	3.1B	3.18B	3.09B	2.98B	2.29B	2.53B	2.24B
Property-Plant & Equipment	1.78B	1.84B	1.73B	1.64B	1.49B	1.14B	867.5M	679.7M	580M
Goodwill & Intangibles	2.95B	1.68B	1.45B	1.49B	1.5B	1.5B	1.46B	1.59B	830.9M
Total Long-Term Assets	6.77B	5.33B	5.2B	5.32B	4.15B	3.5B	3.04B	3.16B	2.27B
Total Assets	13.06B	9.36B	8.29B	8.5B	7.24B	6.49B	5.32B	5.7B	4.51B
Account Payables	197.4M	201.4M	201.9M	204.5M	196.5M	180.4M	134M	116.6M	97.1M
Deferred Revenue	53.7M	n/a	484M	798.4M	630.9M	690.1M	n/a	633.1M	n/a
Short-Term Debt	23.4M	n/a	25.5M	25.5M	27.2M	25.5M	n/a	598M	n/a
Other Current Liabilities	419.3M	398.7M	375.7M	317.2M	263.3M	270.9M	250.5M	206.2M	30.9M
Total Current Liabilities	1.51B	1.2B	1.02B	1.03B	893.9M	902.4M	876.6M	1.4B	532.5M
Long-Term Debt	597.7M	597M	596.3M	595.7M	595M	594.4M	593.8M	438.4M	822.3M
Other Long-Term Liabilities	810.6M	778.4M	797.6M	969.6M	1.1B	784.1M	712.9M	851.8M	536.2M
Total Long-Term Liabilities	1.49B	1.45B	1.46B	1.63B	1.77B	1.44B	1.31B	1.3B	1.36B
Total Liabilities	2.99B	2.64B	2.49B	2.67B	2.66B	2.34B	2.18B	2.7B	1.89B
Total Debt	700M	694.9M	691.3M	690.3M	694.9M	678.8M	593.8M	1.04B	822.3M
Common Stock	654.8M	650.5M	646.3M	642M	636.4M	218.1M	215.2M	212M	242.6M
Retained Earnings	13.17B	8.99B	7.59B	6.07B	4.57B	3.74B	2.69B	2B	3.91B
Comprehensive Income	-244.5M	-242.8M	-254.9M	-157.7M	-161.1M	-156M	-138.5M	-132.7M	-198.4M
Shareholders Equity	10B	6.65B	5.81B	5.84B	4.57B	4.15B	3.14B	2.99B	2.62B
Total Investments	1.24B	1.08B	1.69B	2.44B	1.02B	923.3M	748.7M	1.09B	873.1M